Related content

Where to for pelvic organ prolapse treatment after the FDA pronouncements? Comment

By Pelikan H.  

International Urogynecology Journal, Vol. 24, Iss. 11, 2013-11 ,pp. : 1989-1989

Springer Publishing Company

Access to resources Recommend Favorite

Where to for pelvic organ prolapse treatment after the FDA pronouncements? Reply to Pelikan

By Geelen J.   Dwyer P.  

International Urogynecology Journal, Vol. 24, Iss. 11, 2013-11 ,pp. : 1991-1991

Springer Publishing Company

Access to resources Recommend Favorite

Changes in connective tissue in patients with pelvic organ prolapse—a review of the current literature

By Kerkhof M.   Hendriks L.   Brölmann H.  

International Urogynecology Journal, Vol. 20, Iss. 4, 2009-04 ,pp. : 461-474

Springer Publishing Company

Access to resources Recommend Favorite

Pessary treatment for pelvic organ prolapse and health-related quality of life: a review

By Lamers Babet   Broekman Bart   Milani Alfredo  

International Urogynecology Journal, Vol. 22, Iss. 6, 2011-06 ,pp. : 637-644

Springer Publishing Company

Access to resources Recommend Favorite

Recurrent pelvic organ prolapse in a woman with bladder exstrophy: a case report of surgical management and review of the literature

By Muir Tristi   Aspera A.   Rackley Raymond   Walters Mark  

International Urogynecology Journal, Vol. 15, Iss. 6, 2004-12 ,pp. : 436-438

Springer Publishing Company

Access to resources Recommend Favorite